DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,458,406 | +1.5% | 82,460 | -1.8% | 1.14% | +6.1% |
| Q2 2023 | $20,146,146 | -4.9% | 83,942 | -0.1% | 1.07% | -10.8% |
| Q1 2023 | $21,177,466 | -7.2% | 84,024 | -2.3% | 1.20% | -11.3% |
| Q4 2022 | $22,818,109 | +0.4% | 85,970 | -2.3% | 1.36% | -5.9% |
| Q3 2022 | $22,729,000 | +1.4% | 87,997 | -0.5% | 1.44% | +7.1% |
| Q2 2022 | $22,421,000 | -14.6% | 88,437 | -1.2% | 1.35% | +0.9% |
| Q1 2022 | $26,253,000 | -8.7% | 89,497 | +2.5% | 1.33% | -2.7% |
| Q4 2021 | $28,739,000 | +6.8% | 87,351 | -1.2% | 1.37% | -3.8% |
| Q3 2021 | $26,904,000 | +10.4% | 88,375 | -2.7% | 1.42% | +10.4% |
| Q2 2021 | $24,362,000 | +16.0% | 90,781 | -2.7% | 1.29% | +6.7% |
| Q1 2021 | $20,996,000 | -0.0% | 93,282 | -1.3% | 1.21% | -5.2% |
| Q4 2020 | $20,998,000 | -0.1% | 94,527 | -3.2% | 1.28% | -11.0% |
| Q3 2020 | $21,027,000 | +19.9% | 97,650 | -1.6% | 1.44% | +10.1% |
| Q2 2020 | $17,542,000 | +26.9% | 99,200 | -0.7% | 1.30% | +4.2% |
| Q1 2020 | $13,822,000 | -11.6% | 99,862 | -2.0% | 1.25% | +10.0% |
| Q4 2019 | $15,640,000 | +5.6% | 101,903 | -0.6% | 1.14% | -1.7% |
| Q3 2019 | $14,812,000 | +1.0% | 102,557 | -0.1% | 1.16% | -1.9% |
| Q2 2019 | $14,665,000 | +7.1% | 102,614 | -1.1% | 1.18% | +1.5% |
| Q1 2019 | $13,699,000 | +24.9% | 103,758 | -2.5% | 1.16% | +10.6% |
| Q4 2018 | $10,968,000 | -6.3% | 106,367 | -1.3% | 1.05% | +9.6% |
| Q3 2018 | $11,710,000 | +8.7% | 107,771 | -1.3% | 0.96% | +2.6% |
| Q2 2018 | $10,775,000 | -2.8% | 109,192 | -3.6% | 0.94% | -4.7% |
| Q1 2018 | $11,085,000 | +3.1% | 113,213 | -2.2% | 0.98% | 0.0% |
| Q4 2017 | $10,749,000 | +7.5% | 115,804 | -0.7% | 0.98% | +2.4% |
| Q3 2017 | $10,003,000 | +1.2% | 116,610 | -0.4% | 0.96% | -1.2% |
| Q2 2017 | $9,887,000 | -2.4% | 117,091 | -1.1% | 0.97% | -3.8% |
| Q1 2017 | $10,133,000 | +9.2% | 118,404 | -0.6% | 1.01% | +4.7% |
| Q4 2016 | $9,280,000 | -0.0% | 119,152 | +0.7% | 0.96% | -3.1% |
| Q3 2016 | $9,284,000 | -19.5% | 118,365 | +4.1% | 0.99% | -24.5% |
| Q2 2016 | $11,530,000 | +5.4% | 113,726 | -1.4% | 1.32% | +5.3% |
| Q1 2016 | $10,940,000 | +2.6% | 115,331 | +0.5% | 1.25% | +0.3% |
| Q4 2015 | $10,663,000 | +6.6% | 114,801 | -2.2% | 1.25% | +1.7% |
| Q3 2015 | $9,999,000 | -2.4% | 117,346 | -2.0% | 1.22% | +5.5% |
| Q2 2015 | $10,249,000 | +0.2% | 119,742 | -0.6% | 1.16% | -2.2% |
| Q1 2015 | $10,228,000 | -3.7% | 120,468 | -2.8% | 1.19% | -6.8% |
| Q4 2014 | $10,626,000 | +27.4% | 123,969 | +12.9% | 1.27% | +24.1% |
| Q3 2014 | $8,342,000 | -2.4% | 109,801 | +1.1% | 1.03% | -4.0% |
| Q2 2014 | $8,549,000 | +4.2% | 108,596 | -0.7% | 1.07% | -15.2% |
| Q1 2014 | $8,204,000 | -2.7% | 109,389 | +0.1% | 1.26% | +6.1% |
| Q4 2013 | $8,434,000 | +9.7% | 109,242 | -1.5% | 1.19% | +3.9% |
| Q3 2013 | $7,691,000 | +7.5% | 110,938 | -1.9% | 1.14% | +2.1% |
| Q2 2013 | $7,157,000 | – | 113,067 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |